Search research articles
Contact Us
Filters
Showing results (91-100 of 144) with videos related to
Page
of 15
Sort By:
Cancers
|
September 14, 2024
Targeting Asparagine Metabolism in Well-Differentiated/Dedifferentiated Liposarcoma
Kyle D Klingbeil, Blake R Wilde, Danielle S Graham, et al.
Cell Cycle (Georgetown, Tex.)
|
June 17, 2017
Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide
Kei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.
Journal of Cellular Biochemistry
|
February 9, 2017
High Efficacy of Pazopanib on an Undifferentiated Spindle-Cell Sarcoma Resistant to First-Line Therapy Is Identified With a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model
Kentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.
Oncotarget
|
September 15, 2017
Toxicology and efficacy of tumor-targeting <i>Salmonella typhimurium</i> A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent mice
Yong Zhang, Wenluo Cao, Makoto Toneri, et al.
Journal of Drug Targeting
|
July 20, 2018
Patterns of sensitivity to a panel of drugs are highly individualised for undifferentiated/unclassified soft tissue sarcoma (USTS) in patient-derived orthotopic xenograft (PDOX) nude-mouse models
Kei Kawaguchi, Kentaro Igarashi, Kentaro Miyake, et al.
Oncotarget
|
November 22, 2017
Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model
Kei Kawaguchi, Kentaro Igarashi, Shukuan Li, et al.
Journal of Cellular Biochemistry
|
July 7, 2017
Eribulin regresses a doxorubicin-resistant Ewing's sarcoma with a FUS-ERG fusion and CDKN2A-deletion in a patient-derived orthotopic xenograft (PDOX) nude mouse model
Kentaro Miyake, Takashi Murakami, Tasuku Kiyuna, et al.
Translational Oncology
|
January 4, 2020
Exquisite Tumor Targeting by Salmonella A1-R in Combination with Caffeine and Valproic Acid Regresses an Adult Pleomorphic Rhabdomyosarcoma Patient-Derived Orthotopic Xenograft Mouse Model
Kentaro Igarashi, Kei Kawaguchi, Ming Zhao, et al.
Oncotarget
|
October 6, 2017
A patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncology
Kentaro Igarashi, Takashi Murakami, Kei Kawaguchi, et al.
Histopathology
|
February 26, 2025
Data set for reporting of paediatric rhabdomyosarcoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)
Anna Kelsey, Rita Alaggio, Fleur Webster, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 144) with videos related to
Sort By:
Page
of 15
Cancers
|
September 14, 2024
Targeting Asparagine Metabolism in Well-Differentiated/Dedifferentiated Liposarcoma
Kyle D Klingbeil, Blake R Wilde, Danielle S Graham, et al.
Cell Cycle (Georgetown, Tex.)
|
June 17, 2017
Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide
Kei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.
Journal of Cellular Biochemistry
|
February 9, 2017
High Efficacy of Pazopanib on an Undifferentiated Spindle-Cell Sarcoma Resistant to First-Line Therapy Is Identified With a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model
Kentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.
Oncotarget
|
September 15, 2017
Toxicology and efficacy of tumor-targeting <i>Salmonella typhimurium</i> A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent mice
Yong Zhang, Wenluo Cao, Makoto Toneri, et al.
Journal of Drug Targeting
|
July 20, 2018
Patterns of sensitivity to a panel of drugs are highly individualised for undifferentiated/unclassified soft tissue sarcoma (USTS) in patient-derived orthotopic xenograft (PDOX) nude-mouse models
Kei Kawaguchi, Kentaro Igarashi, Kentaro Miyake, et al.
Oncotarget
|
November 22, 2017
Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model
Kei Kawaguchi, Kentaro Igarashi, Shukuan Li, et al.
Journal of Cellular Biochemistry
|
July 7, 2017
Eribulin regresses a doxorubicin-resistant Ewing's sarcoma with a FUS-ERG fusion and CDKN2A-deletion in a patient-derived orthotopic xenograft (PDOX) nude mouse model
Kentaro Miyake, Takashi Murakami, Tasuku Kiyuna, et al.
Translational Oncology
|
January 4, 2020
Exquisite Tumor Targeting by Salmonella A1-R in Combination with Caffeine and Valproic Acid Regresses an Adult Pleomorphic Rhabdomyosarcoma Patient-Derived Orthotopic Xenograft Mouse Model
Kentaro Igarashi, Kei Kawaguchi, Ming Zhao, et al.
Oncotarget
|
October 6, 2017
A patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncology
Kentaro Igarashi, Takashi Murakami, Kei Kawaguchi, et al.
Histopathology
|
February 26, 2025
Data set for reporting of paediatric rhabdomyosarcoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)
Anna Kelsey, Rita Alaggio, Fleur Webster, et al.
Page
of 15